Shelley Hartman
Chief Executive Officer Aegle Therapeutics
Shelley Hartman is co-founder and CEO of Aegle Therapeutics. Prior to Aegle, Ms. Hartman was the Chairman/CEO of LifeSync Corporation and CEO of GMP Companies, Inc. LifeSync was spun out of GMP, a TPG sponsored life science start-up focused on advancing early-stage biopharmaceutical and medical device product development. Prior to GMP, she was a Managing Director at Goldman, Sachs, specializing in healthcare/life science industries
Seminars
Wednesday 23rd September 2026
AGLE-102 Demonstrates Compelling Efficacy & Safety in a Phase 1/2a Study in Recessive Dystrophic Epidermolysis Bullosa
1:00 pm
- AGLE-102 showed meaningful improvements in wound healing and skin integrity in patients with recessive dystrophic epidermolysis bullosa (RDEB), indicating strong therapeutic potential
- The treatment was well tolerated across the study population, with no significant safety concerns or dose-limiting toxicities reported
- Phase 1/2a results support further development, demonstrating both biological activity and clinical benefit in this high unmet-need genetic disorder
